Characterizing drug resistance in hypoxia-adapted chronic myeloid leukaemia cells.
The development of tyrosine kinase inhibitors (TKI) has improved treatment of chronic myeloid leukaemia (CML) but resistance is observed in patients with advanced-stage CML. Second-generation TKIs overcome most resistance mechanisms but are ineffective against quiescent and hypoxic CML stem cells. M...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Final Year Project |
| 語言: | English |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | http://hdl.handle.net/10356/52743 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
| 機構: | Nanyang Technological University |
| 語言: | English |